Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Financial Development Group is a state-owned enterprise based in Yantai, Shandong Province, China, that provides financial investment and asset management services to support regional industrial growth. The group plays a pivotal role in the local life sciences ecosystem by managing the Yantai Bio-pharmaceutical Industry Fund and providing financing solutions for companies within the Yantai International Bio-tech Park. While not a drug developer itself, it acts as a strategic institutional investor and financial engine for the region's "Bio-pharmaceutical Valley," supporting major biotech and pharmaceutical infrastructure projects. Its activities include equity investment, financing guarantees, and the management of industrial mother funds that target high-tech sectors including healthcare and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai Financial Development Group.